Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Marcucci

Showing results (1-10 of 536) with videos related to

Pageof 54
Sort By:
Blood|August 3, 2013
Arginase-mediated "field" defects in AMLGuido Marcucci
Clinical Advances in Hematology & Oncology : H&O|May 27, 2006
Core binding factor acute myeloid leukemiaGuido Marcucci
Clinical Advances in Hematology & Oncology : H&O|August 25, 2009
Molecular markers in acute myeloid leukemiaGuido Marcucci
Best Practice & Research. Clinical Haematology|March 18, 2008
New approaches in acute myeloid leukemiaWilliam Blum, Guido Marcucci
Current Opinion in Oncology|October 20, 2012
Potential of microRNAs for cancer diagnostics, prognostication and therapyRamiro Garzon, Guido Marcucci
Blood|August 13, 2011
Epigenetic priming: the target?Alice Mims, Guido Marcucci
Haematologica|May 3, 2011
Impact of molecular prognostic factors in cytogenetically normal acute myeloid leukemia at diagnosis and relapseAlison Walker, Guido Marcucci
Blood|February 20, 2016
Not only TKI! Targeting FLT3-ITD by autophagyGuido Marcucci, Ling Li
Clinical Advances in Hematology & Oncology : H&O|February 24, 2006
Targeting epigenetic changes in acute myeloid leukemiaWilliam Blum, Guido Marcucci
Chinese Clinical Oncology|November 6, 2019
More options for older patients with acute myeloid leukemia: venetoclax in combination with low dose cytarabineIbrahim Aldoss, Guido Marcucci
Pageof 54

Showing results (1-10 of 536) with videos related to

Sort By:
Pageof 54
Blood|August 3, 2013
Arginase-mediated "field" defects in AMLGuido Marcucci
Clinical Advances in Hematology & Oncology : H&O|May 27, 2006
Core binding factor acute myeloid leukemiaGuido Marcucci
Clinical Advances in Hematology & Oncology : H&O|August 25, 2009
Molecular markers in acute myeloid leukemiaGuido Marcucci
Best Practice & Research. Clinical Haematology|March 18, 2008
New approaches in acute myeloid leukemiaWilliam Blum, Guido Marcucci
Current Opinion in Oncology|October 20, 2012
Potential of microRNAs for cancer diagnostics, prognostication and therapyRamiro Garzon, Guido Marcucci
Blood|August 13, 2011
Epigenetic priming: the target?Alice Mims, Guido Marcucci
Haematologica|May 3, 2011
Impact of molecular prognostic factors in cytogenetically normal acute myeloid leukemia at diagnosis and relapseAlison Walker, Guido Marcucci
Blood|February 20, 2016
Not only TKI! Targeting FLT3-ITD by autophagyGuido Marcucci, Ling Li
Clinical Advances in Hematology & Oncology : H&O|February 24, 2006
Targeting epigenetic changes in acute myeloid leukemiaWilliam Blum, Guido Marcucci
Chinese Clinical Oncology|November 6, 2019
More options for older patients with acute myeloid leukemia: venetoclax in combination with low dose cytarabineIbrahim Aldoss, Guido Marcucci
Pageof 54